[
    [
        {
            "time": "",
            "original_text": "最前线｜华熙生物2020年营收26亿元，一半以上来自功能性护肤品",
            "features": {
                "keywords": [
                    "华熙生物",
                    "2020年",
                    "营收",
                    "功能性护肤品"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物",
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最前线｜华熙生物2020年营收26亿元，一半以上来自功能性护肤品",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)年报点评报告：品牌建设元年护肤品高增带动Q4营收YOY+73.4% 研发为基生物活性物全产业链开花",
            "features": {
                "keywords": [
                    "华熙生物",
                    "年报",
                    "品牌建设",
                    "护肤品",
                    "高增",
                    "研发",
                    "全产业链"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)年报点评报告：品牌建设元年护肤品高增带动Q4营收YOY+73.4% 研发为基生物活性物全产业链开花",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)2020年年报点评：功能性护肤品强力驱动 全年业绩表现亮眼",
            "features": {
                "keywords": [
                    "华熙生物",
                    "2020年",
                    "年报",
                    "功能性护肤品",
                    "业绩"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)2020年年报点评：功能性护肤品强力驱动 全年业绩表现亮眼",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "国内市场成长空间巨大，医美板块“卷土重来”｜牛熊眼",
            "features": {
                "keywords": [
                    "国内市场",
                    "医美板块",
                    "成长空间",
                    "卷土重来"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国内市场成长空间巨大，医美板块“卷土重来”｜牛熊眼",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华金证券给予华熙生物增持评级，全年业绩正增长，品牌建设推动C端成果显现",
            "features": {
                "keywords": [
                    "华金证券",
                    "华熙生物",
                    "增持评级",
                    "业绩正增长",
                    "品牌建设"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "护肤品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华金证券给予华熙生物增持评级，全年业绩正增长，品牌建设推动C端成果显现",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "210401",
            "original_text": "晨会聚焦210401重点关注纺织服装、医药生物、安克创新、药明康德、新和成、卓胜微、中芯国际-U、华熙生物、周大生、宇信科技",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "医药生物",
                    "华熙生物"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物",
                    "其他行业"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "晨会聚焦210401重点关注纺织服装、医药生物、安克创新、药明康德、新和成、卓胜微、中芯国际-U、华熙生物、周大生、宇信科技",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "社保基金现身10只科创板股前十大流通股东榜",
            "features": {
                "keywords": [
                    "社保基金",
                    "科创板",
                    "流通股东"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科创板"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "社保基金现身10只科创板股前十大流通股东榜",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "口服玻尿酸，是智商税还是财富密码？| 新消费观察",
            "features": {
                "keywords": [
                    "口服玻尿酸",
                    "智商税",
                    "财富密码",
                    "新消费观察"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药生物",
                    "消费品"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "口服玻尿酸，是智商税还是财富密码？| 新消费观察",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        }
    ]
]